Envestnet Portfolio Solutions Inc. Purchases New Position in iShares Biotechnology ETF $IBB

Envestnet Portfolio Solutions Inc. purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 23,563 shares of the financial services provider’s stock, valued at approximately $3,977,000.

A number of other large investors have also recently modified their holdings of the company. Rockport Wealth LLC purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $209,000. Odyssey Capital Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at approximately $479,000. TD Private Client Wealth LLC boosted its holdings in shares of iShares Biotechnology ETF by 164.7% in the fourth quarter. TD Private Client Wealth LLC now owns 17,225 shares of the financial services provider’s stock valued at $2,907,000 after purchasing an additional 10,717 shares during the period. Leuthold Group LLC boosted its holdings in shares of iShares Biotechnology ETF by 41.0% in the fourth quarter. Leuthold Group LLC now owns 18,188 shares of the financial services provider’s stock valued at $3,070,000 after purchasing an additional 5,285 shares during the period. Finally, Beese Fulmer Investment Management Inc. purchased a new stake in iShares Biotechnology ETF during the fourth quarter worth $228,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

iShares Biotechnology ETF stock opened at $169.06 on Friday. The business has a fifty day moving average of $168.95 and a two-hundred day moving average of $169.90. iShares Biotechnology ETF has a twelve month low of $119.78 and a twelve month high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were given a dividend of $0.1218 per share. The ex-dividend date of this dividend was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.